Delivery Order SPE2DR25D2100-SPE2DR26FA0PR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This firm fixed-price delivery order, valued at $13,662.64, represents a non-set-aside competitive award with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication, with a ceiling value of $2,979.09. This is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $23,614.38 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a non-competitive procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract is a child order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 36,000 units of Creon DR 100s capsules, valued at $9,788.44. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, indicating that AmerisourceBergen competed for this order on an open basis. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,157.97 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication. The award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025, and utilized firm fixed price pricing with no set-aside designation. Performance of this delivery order will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,551.61 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for completion by November 18, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency issued a delivery order valued at $14,994.54 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packages. This firm fixed-price delivery order, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a non-competitive award under an existing contract vehicle. The pharmaceutical will be supplied from the vendor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.10 to AmerisourceBergen Drug Corp on July 24, 2025, for 12,000 unit capsules of Creon (pancrelipase) in 100-count bottles. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, carrying an ultimate completion date of July 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR (pancreatic enzyme replacement therapy) in 100-count capsule bottles, with a contract value of $2,449.64 and a completion date of November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 26, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $1,860.18. The contract is a firm fixed-price delivery order with an ultimate completion date of July 7, 2025, and was awarded on July 3, 2025 without a set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0PRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for 36,000 units of Creon DR 100s capsules, valued at $2,704.53. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a child contract under this prime IDC, this delivery order for pancreatic enzyme replacement therapy aligns with AmerisourceBergen's portfolio of specialty medications and brand-name pharmaceuticals supplied to federal healthcare agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/10/25 |